Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             39 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgment of reviewers 2003 2003
21 6 p. 492-
1 p.
artikel
2 Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin Pagliaro, Lance C
2003
21 6 p. 456-462
7 p.
artikel
3 Author/title index, volume 21 2003
21 6 p. 493-499
7 p.
artikel
4 Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results Smith, Joseph A
2003
21 6 p. 483-
1 p.
artikel
5 Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder Raghavan, Derek
2003
21 6 p. 468-474
7 p.
artikel
6 Chemotherapy and cystectomy for muscle invasive bladder cancer Grossman, H.Barton
2003
21 6 p. 463-
1 p.
artikel
7 Critical review of complementary therapies for prostate cancer Chatta, Gurkamal
2003
21 6 p. 491-
1 p.
artikel
8 Current issues in the management of advanced squamous cell carcinoma of the penis Syed, Samira
2003
21 6 p. 431-438
8 p.
artikel
9 Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF), and TNF-related apoptosis-inducing ligand (TRAIL) in prostate cancer Chatta, Gurkamal
2003
21 6 p. 490-491
2 p.
artikel
10 Editorial board 2003
21 6 p. IFC-
1 p.
artikel
11 Essential information for today’s oncologists from the leading health care publisher 2003
21 6 p. I-
1 p.
artikel
12 Extramedullary plasmacytoma invading the bladder: case report and review of the literature López, Alvin
2003
21 6 p. 419-423
5 p.
artikel
13 Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database Moul, Judd W.
2003
21 6 p. 447-455
9 p.
artikel
14 If cystectomy is insufficient, what is an urologist to do? Grossman, H.Barton
2003
21 6 p. 475-478
4 p.
artikel
15 Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy 2003
21 6 p. 486-
1 p.
artikel
16 Information for authors 2003
21 6 p. IBC-
1 p.
artikel
17 Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Carroll, Peter R
2003
21 6 p. 484-
1 p.
artikel
18 Intermittent androgen suppression in patients with prostate cancer Smith, Joseph A
2003
21 6 p. 482-483
2 p.
artikel
19 Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases at Montsouris Institute Smith, Joseph A
2003
21 6 p. 480-481
2 p.
artikel
20 Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer Smith, Joseph A
2003
21 6 p. 481-
1 p.
artikel
21 Masthead/subscription info 2003
21 6 p. ii-
1 p.
artikel
22 Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer Chatta, Gurkamal
2003
21 6 p. 488-
1 p.
artikel
23 Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less DiMarco, David S.
2003
21 6 p. 439-446
8 p.
artikel
24 Neoadjuvant chemotherapy for bladder cancer Millikan, Randall
2003
21 6 p. 464-467
4 p.
artikel
25 Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer Chatta, Gurkamal
2003
21 6 p. 489-
1 p.
artikel
26 Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer Carroll, Peter R
2003
21 6 p. 484-485
2 p.
artikel
27 Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study Carroll, Peter R
2003
21 6 p. 485-486
2 p.
artikel
28 Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 Smith, Joseph A
2003
21 6 p. 482-
1 p.
artikel
29 Quality-of-care indicators for early-stage prostate cancer Carroll, Peter R
2003
21 6 p. 485-
1 p.
artikel
30 Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor Carroll, Peter R
2003
21 6 p. 486-487
2 p.
artikel
31 Renal cell carcinoma (RCC) and telomerase activity: relationship to stage Mekhail, Tarek M.
2003
21 6 p. 424-430
7 p.
artikel
32 Research/clinical fellowship 2003
21 6 p. I-
1 p.
artikel
33 Role of surgeon volume in radical prostatectomy outcomes Smith, Joseph A
2003
21 6 p. 480-
1 p.
artikel
34 Subject index, volume 21 2003
21 6 p. 500-503
4 p.
artikel
35 Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy Chatta, Gurkamal
2003
21 6 p. 487-488
2 p.
artikel
36 Survey section ed. board 2003
21 6 p. 479-
1 p.
artikel
37 Table of contents 2003
21 6 p. iii-iv
nvt p.
artikel
38 The evolving role of docetaxel in the management of androgen independent prostate cancer Chatta, Gurkamal
2003
21 6 p. 489-490
2 p.
artikel
39 Trends in prostate cancer mortality among black men and white men in the United States Carroll, Peter R
2003
21 6 p. 483-484
2 p.
artikel
                             39 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland